This study tested the hypothesis that iron dyshomeostasis might be apparent even via peripherally accessible measurements of hepcidin and parameters related to iron metabolism in AD patients compared to MCI patients, who might also exhibit a usually lesser level of dyshomeostasis, compared to control subjects. This evidence concerns the gene HAMP and Alzheimer disease.